About Life Sciences Advanced Technologies, Inc.

For over 45 years, Life Sciences was the world’s leading commercial producer of native AMV reverse transcriptase. Today, the manufacture of AMV RT  and LSI’s other product offerings is done by Life Sciences Advanced Technologies, Inc., which acquired the assets of LSI in December 2009.  The manufacturing facility, methods and most of the personnel were previously those of Life Sciences, Inc.

Our current products include:

  • nucleic acid modifying enzymes;
  • enzymes and reagent mixes for NASBA and other in isothermal amplification procedures
  • freeze-dried reagent mixes (Accuspheres);
  • high-purity trehalose powder and sterile solution;
  • rabbit anti-avian p27 antiserum, IgG fraction and peroxidase conjugate.

Life Sciences Advanced Technologies also provides a service, using its proprietary technology to lyophilize reagent formulations for PCR, NASBA and other systems.  Such lyophilized products typically demonstrate significantly improved stability that may allow ambient shipping and extended shelf-fie.

For further information about trehalose and its effects in biological systems can be found in a review article by A D. Elbein et al. “New insights on trehalose: a multifunctional molecule” (2003) Glycobiology, 2003, Vol. 13 No. 4 17R – 27R